Andrew Love
About Andrew Love
Andrew Love serves as the Associate Director of Cell Culture Process Development at CytomX Therapeutics, a position he has held since 2019. He has extensive experience in process development, having previously worked at Xoma, Zymergen, and BioMarin.
Work at CytomX Therapeutics
Andrew Love serves as the Associate Director of Cell Culture Process Development at CytomX Therapeutics. He has held this position since 2019, contributing to the company's focus on developing innovative therapies. His role involves overseeing the development and optimization of cell culture processes, which are critical for the production of therapeutic proteins.
Previous Experience in Process Development
Before joining CytomX Therapeutics, Andrew Love worked at Xoma as a Process Development Associate II from 2006 to 2009 and later as a Senior Associate in Process Development from 2011 to 2012. His experience at Xoma provided him with a solid foundation in process development, which he leveraged in subsequent roles.
Experience at Zymergen, Inc.
Andrew Love was employed at Zymergen, Inc. as Group Leader of Fermentation Operations from 2017 to 2019. In this role, he managed fermentation processes, contributing to the company's advancements in biotechnology. His leadership in this area enhanced operational efficiencies and supported product development.
Career at BioMarin
Andrew Love worked as a Scientist at BioMarin from 2012 to 2017. During his tenure, he focused on various aspects of scientific research and development, contributing to the company's mission of developing innovative biopharmaceuticals for serious diseases.
Education and Expertise
Andrew Love earned a Bachelor of Science degree in Animal Physiology and Neuroscience from UC San Diego, where he studied from 1996 to 2000. His educational background provides him with a strong understanding of biological systems, which is essential for his roles in biotechnology and process development.